BACKGROUND: Vitamin D influences cellular proliferation and proliferation-related breast tissue characteristics, such as mammographic breast density. Little is known about vitamin D status, assessed by serum 25-hydroxyvitamin D [25(OH)D], and its relationship to breast density in breast cancer survivors. METHODS: Participants were 426 postmenopausal breast cancer survivors from the Health, Eating, Activity, and Lifestyle Study. Women from New Mexico, Los Angeles, and western Washington were enrolled postdiagnosis. Data for this report are from an examination conducted 24 months postenrollment. Participants completed health-related questionnaires, gave fasting blood samples, and completed height and weight measurements. Serum [25(OH)D] was assayed by radioimmunoabsorbant assay. Breast dense area and percent density were measured from postdiagnosis-digitized mammograms. Multivariate linear regression tested associations of serum [25(OH)D] with mammographic breast density measures. RESULTS: Of the 426 participants, 22.8% were African-American, 11.3% were Hispanic, and 62.8% were non-Hispanic white. We observed no associations of serum [25(OH)D] with either breast density or breast dense area. Among women with vitamin D deficiency (serum [25(OH)D], <16.0 ng/mL; n = 103), mean percent breast density was 8.0%, and among those with sufficient status (n = 99; serum [25(OH)D], > or = 32.0 ng/mL), mean percent density was 8.5%. Breast dense area averaged 27.2 and 26.2 cm2 for women with vitamin D deficiency and sufficiency, respectively. CONCLUSION: Data from this multiethnic cohort of breast cancer survivors do not support the hypothesis that serum vitamin D, [25(OH)D], is associated with breast density in cancer survivors.
BACKGROUND:Vitamin D influences cellular proliferation and proliferation-related breast tissue characteristics, such as mammographic breast density. Little is known about vitamin D status, assessed by serum 25-hydroxyvitamin D [25(OH)D], and its relationship to breast density in breast cancer survivors. METHODS:Participants were 426 postmenopausal breast cancer survivors from the Health, Eating, Activity, and Lifestyle Study. Women from New Mexico, Los Angeles, and western Washington were enrolled postdiagnosis. Data for this report are from an examination conducted 24 months postenrollment. Participants completed health-related questionnaires, gave fasting blood samples, and completed height and weight measurements. Serum [25(OH)D] was assayed by radioimmunoabsorbant assay. Breast dense area and percent density were measured from postdiagnosis-digitized mammograms. Multivariate linear regression tested associations of serum [25(OH)D] with mammographic breast density measures. RESULTS: Of the 426 participants, 22.8% were African-American, 11.3% were Hispanic, and 62.8% were non-Hispanic white. We observed no associations of serum [25(OH)D] with either breast density or breast dense area. Among women with vitamin D deficiency (serum [25(OH)D], <16.0 ng/mL; n = 103), mean percent breast density was 8.0%, and among those with sufficient status (n = 99; serum [25(OH)D], > or = 32.0 ng/mL), mean percent density was 8.5%. Breast dense area averaged 27.2 and 26.2 cm2 for women with vitamin Ddeficiency and sufficiency, respectively. CONCLUSION: Data from this multiethnic cohort of breast cancer survivors do not support the hypothesis that serum vitamin D, [25(OH)D], is associated with breast density in cancer survivors.
Authors: JoEllen Welsh; Jennifer A Wietzke; Glendon M Zinser; Belinda Byrne; Kelly Smith; Carmen J Narvaez Journal: J Nutr Date: 2003-07 Impact factor: 4.798
Authors: Susan M Gapstur; Pilar López; Laura A Colangelo; Judith Wolfman; Linda Van Horn; R Edward Hendrick Journal: Cancer Epidemiol Biomarkers Prev Date: 2003-10 Impact factor: 4.254
Authors: Anne McTiernan; Kumar B Rajan; Shelley S Tworoger; Melinda Irwin; Leslie Bernstein; Richard Baumgartner; Frank Gilliland; Frank Z Stanczyk; Yutaka Yasui; Rachel Ballard-Barbash Journal: J Clin Oncol Date: 2003-05-15 Impact factor: 44.544
Authors: Marian L Neuhouser; Bess Sorensen; Bruce W Hollis; Anita Ambs; Cornelia M Ulrich; Anne McTiernan; Leslie Bernstein; Sharon Wayne; Frank Gilliland; Kathy Baumgartner; Richard Baumgartner; Rachel Ballard-Barbash Journal: Am J Clin Nutr Date: 2008-07 Impact factor: 7.045
Authors: Zhengjia Chen; Anna H Wu; W James Gauderman; Leslie Bernstein; Huiyan Ma; Malcolm C Pike; Giske Ursin Journal: Am J Epidemiol Date: 2004-01-15 Impact factor: 4.897
Authors: Marian L Neuhouser; JoAnn E Manson; Amy Millen; Mary Pettinger; Karen Margolis; Elizabeth T Jacobs; James M Shikany; Mara Vitolins; Lucile Adams-Campbell; Simin Liu; Erin LeBlanc; Karen C Johnson; Jean Wactawski-Wende Journal: Am J Epidemiol Date: 2012-02-22 Impact factor: 4.897
Authors: Digant Gupta; Pankaj G Vashi; Kristen Trukova; Christopher G Lis; Carolyn A Lammersfeld Journal: Exp Ther Med Date: 2011-01-20 Impact factor: 2.447
Authors: Brian L Sprague; Amy Trentham-Dietz; Ronald E Gangnon; Diana S M Buist; Elizabeth S Burnside; Erin J Aiello Bowles; Frank Z Stanczyk; Gale S Sisney; Halcyon G Skinner Journal: Breast Cancer Res Treat Date: 2011-08-17 Impact factor: 4.872
Authors: Kimberly A Bertrand; Bernard Rosner; A Heather Eliassen; Susan E Hankinson; Kathryn M Rexrode; Walter Willett; Rulla M Tamimi Journal: Breast Cancer Res Treat Date: 2014-12-28 Impact factor: 4.872
Authors: Loreen Straub; Johanna Riedel; Peter B Luppa; Johanna Wissing; Almut Artmann; Marion Kiechle; Vanadin Regina Seifert-Klauss Journal: Geburtshilfe Frauenheilkd Date: 2017-03 Impact factor: 2.915
Authors: Alecia Malin Fair; Toni J Lewis; Maureen Sanderson; William D Dupont; Sarah Fletcher; Kathleen M Egan; Anthony C Disher Journal: Nutr Res Date: 2015-07-31 Impact factor: 3.315